Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2010

Evens AM, Roy R, Sterrenberg D, Moll MZ, Chadburn A, Gordon LI. Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy. Curr Oncol Rep. 2010;12(6):383-94.

Koolaee RM, Singer O, Bass A, Winchester R, Seshan S, Erkan D. Hepatitis C- and human immunodeficiency virus-induced hypersensitivity vasculitis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS J. 2010;6(1):102-7.

Greenblatt MB, Shim J-, Zou W, Sitara D, Schweitzer M, Hu D, et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest. 2010;120(7):2457-73.

Seidman JD, Yemelyanova AV, Khedmati F, Bidus MA, Dainty L, Boice CR, et al. Prognostic factors for stage I ovarian carcinoma. Int J Gynecol Pathol. 2010;29(1):1-7.

Fonseca R, Richardson P, Giralt S, Lonial S, S Rajkumar V, A Stewart K, et al. Conflicts of interest, authorship, and disclosures in industry-related scientific publications. Mayo Clin Proc. 2010;85(2):197-9; author reply 201-4.

Arinsburg SA, Skerrett DL, Kleinert D, Giardina PJ, Cushing MM. The significance of a positive DAT in thalassemia patients. Immunohematology. 2010;26(3):87-91.

Dadhania D, Snopkowski C, Ding R, Muthukumar T, Lee J, Bang H, et al. Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation. 2010;90(2):189-97.

Ambrogini E, Almeida M, Martin-Millan M, Paik J-, DePinho RA, Han L, et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 2010;11(2):136-46.

Tervaert TW, Mooyaart AL, Amann K, Cohen AH, H Cook T, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556-63.

Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, et al. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol. 2010;28(25):3958-64.